HGH Holdings Statistics

Total Valuation

HGH Holdings has a market cap or net worth of SGD 23.15 million. The enterprise value is 23.26 million.

Market Cap	23.15M
Enterprise Value	23.26M

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

HGH Holdings has 1.78 billion shares outstanding. The number of shares has increased by 6.95% in one year.

Current Share Class	n/a
Shares Outstanding	1.78B
Shares Change (YoY)	+6.95%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	59.99%
Owned by Institutions (%)	9.77%
Float	712.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.40
PB Ratio	0.51
P/TBV Ratio	n/a
P/FCF Ratio	2,653.13
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.56, with an EV/FCF ratio of 2,665.73.

EV / Earnings	-358.04
EV / Sales	1.33
EV / EBITDA	7.56
EV / EBIT	n/a
EV / FCF	2,665.73

Financial Position

The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.12.

Current Ratio	2.19
Quick Ratio	1.87
Debt / Equity	0.12
Debt / EBITDA	1.78
Debt / FCF	629.15
Interest Coverage	-5.83

Financial Efficiency

Return on equity (ROE) is -0.18% and return on invested capital (ROIC) is -1.10%.

Return on Equity (ROE)	-0.18%
Return on Assets (ROA)	-0.88%
Return on Capital (ROIC)	-1.10%
Revenue Per Employee	80,839
Profits Per Employee	-301
Employee Count	216
Asset Turnover	0.27
Inventory Turnover	64.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.27%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	46.72
Average Volume (20 Days)	691,925

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HGH Holdings had revenue of SGD 17.46 million and -64,968 in losses. Loss per share was -0.00.

Revenue	17.46M
Gross Profit	4.54M
Operating Income	-897,476
Pretax Income	-244,539
Net Income	-64,968
EBITDA	2.69M
EBIT	-897,476
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 5.31 million in cash and 5.49 million in debt, giving a net cash position of -177,000 or -0.00 per share.

Cash & Cash Equivalents	5.31M
Total Debt	5.49M
Net Cash	-177,000
Net Cash Per Share	-0.00
Equity (Book Value)	45.24M
Book Value Per Share	0.03
Working Capital	4.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.11 million and capital expenditures -4.10 million, giving a free cash flow of 8,726.

Operating Cash Flow	4.11M
Capital Expenditures	-4.10M
Free Cash Flow	8,726
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 25.97%, with operating and profit margins of -5.14% and -0.37%.

Gross Margin	25.97%
Operating Margin	-5.14%
Pretax Margin	-1.40%
Profit Margin	-0.37%
EBITDA Margin	15.43%
EBIT Margin	-5.14%
FCF Margin	0.05%

Dividends & Yields

HGH Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.95%
Shareholder Yield	-6.95%
Earnings Yield	-0.26%
FCF Yield	0.04%

Stock Splits

The last stock split was on November 25, 2016. It was a forward split with a ratio of 5.359056806.

Last Split Date	Nov 25, 2016
Split Type	Forward
Split Ratio	5.359056806

Scores

HGH Holdings has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a